Modulation of noradrenaline release by B-1 and B-2 kinin receptors during metabolic anoxia in the rat isolated atria

被引:9
作者
Foucart, S [1 ]
Grondin, L [1 ]
Couture, R [1 ]
Nadeau, R [1 ]
机构
[1] HOP SACRE COEUR,CTR RECH,MONTREAL,PQ H4J 1C5,CANADA
关键词
bradykinin; noradrenaline release; kinin receptors; metabolic anoxia; rat atria;
D O I
10.1139/cjpp-75-6-639
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A model of metabolic anoxia was used to investigate the modulatory effect of bradykinin (BK) on the release of noradrenaline (NA) in isolated rat atria. Atria were isolated from Wistar rats and inserted into a perfusion system. After an equilibration period of 20 min, the perfusate was collected every 5 min for a period of 85 min, during which the atria were field stimulated (5 Hz, 2 ms, 50 mA, 60 s) at 10 (S-1) and 75 (S-2) min. The metabolic anoxia was started 40 min before S-2 by replacing O-2 with N-2 and by removing glucose. The drugs were added 20 min before S-2, and their effects on NA release were assessed by the ratio S-2/S-1. The spontaneous and electrically stimulated induced (S-I) releases of NA were significantly increased by the anoxic procedure. BK (30 nM) significantly increased the S-I release of NA under normoxic conditions. However, under anoxia, BK had no effect on the S-I release of NA but inhibited its spontaneous release. BK coadministered with HOE-140 (100 nM), a B-2 receptor antagonist, significantly increased the S-I release of NA during anoxia, whereas the coadministration of BK with Leu(8)-des-Arg(9)-BK (100 nM), a B-1 receptor antagonist, significantly inhibited that release. Administration of des-Arg(9)-BK (100 nM) had no effect on the S-I outflow of NA following anoxia, although its coadministration with a B-1 antagonist resulted in a significant inhibition of the S-I outflow of NA. The present results suggest that BK inhibits NA release through the activation of a B-2 receptor following a 40-min period of metabolic anoxia. Because this inhibition can be observed only in the presence of a B-1 receptor antagonist, this could imply that B-1 receptor activation, revealed by the anoxia, is involved in the facilitation of NA release.
引用
收藏
页码:639 / 645
页数:7
相关论文
共 40 条
  • [1] ISCHEMIA-INDUCED LOCAL RELEASE OF MYOCARDIAL NORADRENALINE
    ABRAHAMSSON, T
    ALMGREN, O
    CARLSSON, L
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 : S19 - S22
  • [2] PRESYNAPTIC EFFECTS OF EPINEPHRINE ON NOREPINEPHRINE RELEASE FROM CARDIAC SYMPATHETIC-NERVES IN DOGS
    BOUDREAU, G
    PERONNET, F
    DECHAMPLAIN, J
    NADEAU, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01): : H205 - H211
  • [3] KININ-FORMING ENZYME OF RAT CARDIAC TISSUE - SUB-CELLULAR DISTRIBUTION AND BIOCHEMICAL-PROPERTIES
    BRITOS, J
    NOLLY, H
    [J]. HYPERTENSION, 1981, 3 (06) : 42 - 45
  • [4] BRADYKININ PEPTIDES IN KIDNEY, BLOOD, AND OTHER TISSUES OF THE RAT
    CAMPBELL, DJ
    KLADIS, A
    DUNCAN, AM
    [J]. HYPERTENSION, 1993, 21 (02) : 155 - 165
  • [5] RAMIPRILAT ATTENUATES THE LOCAL RELEASE OF NORADRENALINE IN THE ISCHEMIC MYOCARDIUM
    CARLSSON, L
    ABRAHAMSSON, T
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (02) : 157 - 164
  • [6] PROTECTIVE EFFECTS OF BRADYKININ ON THE ISCHEMIC HEART - IMPLICATION OF THE B1 RECEPTOR
    CHAHINE, R
    ADAM, A
    YAMAGUCHI, N
    GASPO, R
    REGOLI, D
    NADEAU, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) : 318 - 322
  • [7] MODULATORY EFFECT OF BRADYKININ ON THE RELEASE OF NORADRENALINE FROM RAT ISOLATED ATRIA
    CHULAK, C
    COUTURE, R
    FOUCART, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (02) : 330 - 334
  • [8] METABOLIC REQUIREMENTS FOR RELEASE OF ENDOGENOUS NORADRENALINE DURING MYOCARDIAL-ISCHEMIA AND ANOXIA
    DART, AM
    RIEMERSMA, RA
    SCHOMIG, A
    UNGAR, A
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (01) : 43 - 50
  • [9] RELEASE OF ENDOGENOUS CATECHOLAMINES IN THE ISCHEMIC MYOCARDIUM OF THE RAT .B. EFFECT OF SYMPATHETIC-NERVE STIMULATION
    DART, AM
    SCHOMIG, A
    DIETZ, R
    MAYER, E
    KUBLER, W
    [J]. CIRCULATION RESEARCH, 1984, 55 (05) : 702 - 706
  • [10] DENDORFER A, 1995, N-S ARCH PHARMACOL, V351, P274